EUVIMEDEUVIMED entdecken
Crossref

Exploring Epstein-Barr virus testing patterns and positivity rates: A retrospective analysis

Diksha Rana, Biman Saikia, Deepti Suri, Pankaj Malhotra, Vikas Suri, Ashish Sharma, Aman Sharma, Seema Chhabra

Journal of Laboratory Physicians · 07.11.2026 · 1-8

DOI: 10.25259/jlp_61_2026 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Laboratory Physicians, online erschienen am 07.11.2026. Verfasst von Diksha Rana und 7 weiteren Autor:innen. Die Arbeit nennt 23 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Epstein-Barr virus (EBV) is associated with a broad spectrum of clinical conditions. However, real-world data on EBV DNA testing patterns and positivity across clinical settings remain limited. We evaluated testing trends, clinical indications, EBV-DNA positivity rates, and viral load distribution across major clinical groups in a tertiary-care setting. Materials and Methods: We retrospectively analyzed EBV DNA testing data from 404 patients tested using whole blood at a tertiary-care center in North India between 2024 and 2025. Viral loads were quantified by real-time polymerase chain reaction. Testing indications, detection rates, and viral load distributions were evaluated across clinical subgroups. Statistical analysis: Categorical variables were compared using the χ 2 test or Fisher’s exact test. Normality was assessed using the Shapiro-Wilk test, followed by the Kruskal-Wallis test for multiple comparisons of viral load data.

Results

EBV DNA was detected in 25.50% of cases. The highest positivity rate (36.84%) was observed among patients with secondary immunodeficiency, all of whom were human immunodeficiency virus (HIV) positive. Lymphoproliferative disorders constituted the largest referral group (26.48%), followed by renal transplant recipients (12.62%). Median viral loads were highest among HIV-positive patients (1.67 × 10 5 copies/mL) and renal transplant recipients (1.26 × 10 5 copies/mL).

Conclusion

EBV-DNA testing was requested across diverse clinical settings, extending beyond traditionally recognized high-risk populations such as transplant recipients and patients with immunodeficiency. HIV-positive individuals showed the highest observed positivity rate and median viral load. These findings provide a real-world overview of EBV-DNA testing patterns and EBV DNAemia across diverse clinical populations.

Zitieren

APA

Rana, D., Saikia, B., Suri, D., Malhotra, P., Suri, V., Sharma, A., Sharma, A., & Chhabra, S. (2026). Exploring Epstein-Barr virus testing patterns and positivity rates: A retrospective analysis. Journal of Laboratory Physicians, 0, 1-8. https://doi.org/10.25259/jlp_61_2026

Vancouver

Rana D, Saikia B, Suri D, Malhotra P, Suri V, Sharma A, et al. Exploring Epstein-Barr virus testing patterns and positivity rates: A retrospective analysis. Journal of Laboratory Physicians. 2026;0:1-8. doi:10.25259/jlp_61_2026

BibTeX
@article{Rana2026,
  author = {Rana, Diksha and Saikia, Biman and Suri, Deepti and Malhotra, Pankaj and Suri, Vikas and Sharma, Ashish and Sharma, Aman and Chhabra, Seema},
  title = {Exploring Epstein-Barr virus testing patterns and positivity rates: A retrospective analysis},
  journal = {Journal of Laboratory Physicians},
  year = {2026},
  volume = {0},
  pages = {1--8},
  doi = {10.25259/jlp_61_2026}
}
Kostenlos starten →